Janssen Reminyl Benefit Seen Among Probable Vascular Dementia Patients
Executive Summary
A study of Janssen's Reminyl (galantamine) showed benefits in patients with probable vascular dementia as well as patients with Alzheimer's disease with cerebrovascular components.